Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  WHTCF | T.WELL.DB

WELL Health Technologies Corp. is a Canada-based practitioner-focused digital healthcare company. Its healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. Its business units include Canadian Patient Services, WELL Health USA Patient and Provider Services, and SaaS and Technology Services. Its solutions enable more than 38,000 healthcare providers between the United States and Canada and power owned and operated healthcare ecosystem in Canada with over 200 clinics supporting primary care, specialized care, and diagnostic services. In the United States its solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, and mental health. WELL Health USA Patient and Provider Services consists of four assets: CRH Medical, Provider Staffing, Circle Medical and Wisp. It provides cybersecurity protection and patient data privacy solutions.


TSX:WELL - Post by User

Post by speedy99on Dec 08, 2021 8:31am
205 Views
Post# 34209728

WELL - market correction opportunity

WELL - market correction opportunity

Top 3 Opportunities in This Market Correction

The market correction has created attractive long-term opportunities in stocks like WELL Health Technologies (TSX:WELL).

NVEILACLACNVEIWELL
falling red arrow and lifting

Image source: Getty Images

We’re in the middle of a market correction. High-flying growth stocks and tech companies have lost billions of dollars in market capitalization this year. There are some signs that this trend could continue. That’s excellent news for bargain hunters who are looking for undervalued, long-term opportunities. 

Here are the top three beaten-down opportunities worth your attention in this bear market. 

Market correction opportunity #1

Nuvei (TSX:NVEI) (NASDAQ:NVEI) has hit a vicious speed bump in its growth journey. Nuvei stock is down 25% in November and a whopping 36% from its all-time high earlier this year. Investors seem to have simply lost their appetite for high-growth payment processors, since the entire industry is in a downtrend at the moment. 

Admittedly, Nuvei’s valuation was a bit stretched earlier in this cycle. The stock was trading at a price-to-earnings (P/E) ratio of 150. That’s now down to 116. For most companies, a triple-digit P/E ratio could be considered overvalued. However, Nuvei registered 96% year-over-year revenue growth in its most recent quarter. That means the P/E-growth, or PEG, ratio is roughly 1.2. 

In short, Nuvei is fairly valued at the moment. 

Market correction opportunity #2

Remember the telehealth star that delivered a 300% return last year? Well, it’s now down 42% from an all-time high and is starting to look like a bargain. WELL Health Technologies (TSX:WELL) is currently trading at $5.24 — the same level as in August 2020. 

However, the company’s fundamentals and market position have improved dramatically. Last year’s acquisitions have made WELL Health the biggest operator of private clinics in Canada and a serious contender in America’s telehealth space. This year, the company is on track to generate $400 million in recurring revenue. 

Meanwhile, WELL Health’s market cap has dropped to $1.08 billion. That implies a price-to-recurring revenue ratio of 2.7! It’s unbelievably underpriced. That’s why I’m adding more to my position over the next few months. I encourage you to take a closer look, too. 

Market correction opportunity #3

Lithium Americas (TSX:LAC)(NYSE:LAC) is the last pick on this list. Lithium, as you well know, is a critical component of most mainstream batteries. That means everything from your laptop to your electric car uses a considerable amount of lithium to power itself. Unsurprisingly, demand for this commodity is as high as ever. 

However, the downturn in tech stocks and the global economy these past few months has impacted LAC, too. The stock has lost roughly 20% of its value over the past week alone. That puts it firmly in “bear market” territory. 

Over the long term, lithium producers face a severe demand-supply imbalance. Consumers will need electronics and EVs at a faster pace than manufacturers can deliver them. That makes LAC a unique opportunity for the next decade. Add this to your growth watchlist for 2022.


<< Previous
Bullboard Posts
Next >>